Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation
β Scribed by R. J. Portman; H. U. Meier-Kriesche; R. Swinford; P. Brannan; B. D. Kahan
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 72 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cyclosporine (Sandimmune; Novartis Pharmaceuticals UK Ltd) is an effective immunosuppressive drug, but its lipid formulation and variable absorption may expose children to the risk of rejection during episodes of gastroenteritis after liver transplantation. Neoral (Novartis) is a microemulsified for
The intraindividual variability and circadian variation of oral cyclosporine (CsA) pharmacokinetics were studied over 24 h in 18 renal transplant recipients at steady state, and in 10 of the patients during a second 24 h period. The absolute percentage intraindividual difference in daytime AUC (0-12